Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FQNL3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,642
Award facts
- Contract value 100% obligated
- $15,641.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL configuration, with a ceiling value of $15,641.84. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor and is scheduled for ultimate completion by August 18, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contract awards predominantly through the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracting activity demonstrates consistent capability in fulfilling military and veteran healthcare pharmaceutical needs through open competition, with delivery orders utilizing firm fixed-price structures across varying order values. This specific Cosentyx delivery order supports the company's role as a primary pharmaceutical supplier to the Defense Health Agency and other government healthcare systems requiring specialty medications and branded pharmaceutical products for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FQNL3?
SPE2DB25FQNL3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FQNL3 worth?
The government has obligated $15,642 on SPE2DB25FQNL3.
Is contract SPE2DB25FQNL3 an order under another contract?
Yes. SPE2DB25FQNL3 is a delivery order under SPE2DB20D7059, an indefinite delivery contract.
Was contract SPE2DB25FQNL3 competed?
The extent of competition for SPE2DB25FQNL3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award